Search Results - "Lehmann, Anders"

Refine Results
  1. 1

    Intestinal SGLT1 in metabolic health and disease by Lehmann, Anders, Hornby, Pamela J

    “…The Na(+)-glucose cotransporter 1 (SGLT1/SLC5A1) is predominantly expressed in the small intestine. It transports glucose and galactose across the apical…”
    Get more information
    Journal Article
  2. 2

    Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy by Sanne Bøjet, Larsen, Bertil, Ladefoged, Anders Lehmann Dahl, Pedersen, Jens Kæstel, Skov, Tor Skibsted, Clemmensen, Steen Hvitfeldt, Poulsen

    Published in Annals of medicine (Helsinki) (01-12-2024)
    “…Increased diagnostic awareness and specific disease treatments have changed the landscape of transthyretin cardiac amyloidosis (ATTR). Patients with wild-type…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Incidence and predictors of worsening heart failure in patients with wild‐type transthyretin cardiac amyloidosis by Ladefoged, Bertil Thyrsted, Dybro, Anne, Dahl Pedersen, Anders Lehmann, Rasmussen, Torsten Bloch, Vase, Henrik Ølholm, Clemmensen, Tor Skibsted, Gillmore, Julian, Poulsen, Steen Hvitfeldt

    Published in ESC Heart Failure (01-10-2022)
    “…Background Prognostic markers of survival have been identified in wild‐type transthyretin amyloidosis (ATTRwt), but limited data exist with respect to…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain by Morabito, Michael V, Ravussin, Yann, Mueller, Bridget R, Skowronski, Alicja A, Watanabe, Kazuhisa, Foo, Kylie S, Lee, Samuel X, Lehmann, Anders, Hjorth, Stephan, Zeltser, Lori M, LeDuc, Charles A, Leibel, Rudolph L

    Published in PloS one (20-01-2017)
    “…Diet-induced obesity (DIO) resulting from consumption of a high fat diet (HFD) attenuates normal neuronal responses to leptin and may contribute to the…”
    Get full text
    Journal Article
  11. 11

    Effects of a novel MC4R agonist on maintenance of reduced body weight in diet‐induced obese mice by Skowronski, Alicja A., Morabito, Michael V., Mueller, Bridget R., Lee, Samuel, Hjorth, Stephan, Lehmann, Anders, Watanabe, Kazuhisa, Zeltser, Lori M., Ravussin, Yann, Rosenbaum, Michael, LeDuc, Charles A., Leibel, Rudolph L.

    Published in Obesity (Silver Spring, Md.) (01-05-2014)
    “…Objective The physiology of the weight‐reduced (WR) state suggests that pharmacologic agents affecting energy homeostasis may have greater efficacy in WR…”
    Get full text
    Journal Article
  12. 12

    Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia by Rydholm, Hans, MD, PhD, von Corswant, Christian, PhD, Denison, Hans, MD, PhD, Jensen, Jörgen M., PhD, Lehmann, Anders, PhD, Ruth, Magnus, MD, PhD, Söderlind, Erik, PhD, Aurell-Holmberg, Ann, M Med Sci

    Published in Clinical therapeutics (01-04-2016)
    “…Abstract Purpose Lesogaberan, a γ-aminobutyric acid (GABA)B receptor agonist, was developed for the treatment of gastroesophageal reflux disease in patients…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons by Page, Amanda J., Young, Richard L., Martin, Chris M., Umaerus, Mia, O’Donnell, Tracey A., Cooper, Nicole J., Coldwell, Jonathan R., Hulander, Malin, Mattsson, Jan P., Lehmann, Anders, Blackshaw, L. Ashley

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-2005)
    “…Background & Aims: Inhibitory G-protein-coupled receptors have demonstrated potential in treatment of gastroesophageal reflux disease (GERD) through actions on…”
    Get full text
    Journal Article
  15. 15

    Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs by Lehmann, Anders, Blackshaw, L.Ashley, Brändén, Lena, Carlsson, Anita, Jensen, Jörgen, Nygren, Emelie, Smid, Scott D.

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-2002)
    “…Background & Aims: Transient lower esophageal sphincter relaxations (TLESRs) are the major cause of gastroesophageal acid reflux, and are triggered by…”
    Get full text
    Journal Article
  16. 16

    4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease by Jirholt, Johan, Asling, Bengt, Hammond, Paul, Davidson, Geoffrey, Knutsson, Mikael, Walentinsson, Anna, Jensen, Jörgen M, Lehmann, Anders, Agreus, Lars, Lagerström-Fermer, Maria

    Published in PloS one (28-04-2011)
    “…Gastro-esophageal reflux disease (GERD) is partly caused by genetic factors. The underlying susceptibility genes are currently unknown, with the exception of…”
    Get full text
    Journal Article
  17. 17

    Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists by Blackshaw, L A, Staunton, E, Lehmann, A, Dent, J

    Published in The American journal of physiology (01-10-1999)
    “…Transient lower esophageal sphincter (LES) relaxation is the major mechanism of gastroesophageal reflux. This study uses an established ferret model to…”
    Get full text
    Journal Article
  18. 18

    GABAB receptors as drug targets to treat gastroesophageal reflux disease by Lehmann, Anders

    Published in Pharmacology & therapeutics (Oxford) (01-06-2009)
    “…For many years, acid-suppressive therapy has been at the forefront of treating gastroesophageal reflux disease (GERD), yet despite the advent of the proton…”
    Get full text
    Journal Article
  19. 19
  20. 20